Moderate to Severe Vernal Keratoconjunctivitis

1

Review clinical trials related to Moderate to Severe Vernal Keratoconjunctivitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis

Participants needed: 120
Trial details
Phase: Phase 2Age: 4-17Biological sex: AllType: InterventionalSponsor: Laboratoires TheaUpdated: Apr 22, 2026Locations: 11
Eligibility criteria

Informed consent signed and dated [+2]